Itonis (Itonis) Accounts Receivable : $0.00 Mil (As of Feb. 2008)

View and export this data going back to 2007. Start your Free Trial

What is Itonis Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Itonis's accounts receivables for the quarter that ended in Feb. 2008 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Itonis's Net-Net Working Capital per share for the quarter that ended in Feb. 2008 was $-0.01.

Itonis Accounts Receivable Historical Data

The historical data trend for Itonis's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Accounts Receivable Chart

Itonis Annual Data

Trend

Nov05

Nov06

Nov07

Accounts Receivable

0.01

Itonis Quarterly Data
	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08
Accounts Receivable	Get a 7-Day Free Trial					0.12	0.14	0.03	-	-

Itonis Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Itonis Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Itonis's Days Sales Outstanding for the quarter that ended in Feb. 2008 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.003	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Itonis's accounts receivable are only considered to be worth 75% of book value:

Itonis's Net-Net Working Capital Per Share for the quarter that ended in Feb. 2008 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.132	+	0.75 * 0.003	+	0.5 * 0	-	1.177
-	0	-	0)	/	124.93
=	-0.01

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Itonis Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Itonis's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Itonis (Itonis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Accounts Receivable

Comparable Companies

FZMD SNYR SGMFF PMC EBOSF OMI UDHCF PBH PDCO SHPMY SHTDY HSIC ABC CAH MCK

Traded in Other Exchanges

N/A

Address

22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630

Website

http://www.itonisholdings.com

Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines

From GuruFocus

Itonis, Inc. announces “Emesyl® Plus” homeopathic nasal spray containing Premium Hemp Oil

By Marketwired Marketwired • 09-26-2018